Barcelona City Council | Capital humàBarcelona City Council website

Home  > Job profiles





In compliance with Organic Law 15/1999, of 13 December, under the Personal Data Protection Act, we inform you that data collected will form part of an automated file, under the ownership of BARCELONA ACTIVE SPM S.A., with registered office at 162-164 Calle Llacuna, Barcelona, with the aim of managing enrollments and of informing of the company's activities and services within its field of action. You will be able to exercise access rights, rectification, cancel cancellation and/or opposition via written communication to the Legal Services of BARCELONA ACTIVE SPM S.A. at the aforementioned address.

Get to know this occupation

Other denominations

Principal investigator


The Law on Medicinal Products defines clinical trials as "all experimental evaluation of a substance or drug through its administration or application to human beings". The process for the approval of a new medication for human use is complex and time consuming. After pre-clinical investigation (in vitro and in animals), a new drug is tested on humans during clinical trials (phase II, phase III and phase IV, depending on the type of population and number of patients included). The whole process usually involves at least 3,000 people, lasts between five and ten years, and can have a total cost of between 300 and 500 million euros. Registration requires presenting all the scientific documentation of consecutive protocols and the results obtained.

The clinical trial coordinator is the person responsible for the clinical trials of a (bio) pharmaceutical company or CRO (Contract Research Organization). In general, this professional directs a team of several specialists in different fields (assistants, clinical trial monitors, biostatisticians and computer engineers). This requires close collaboration with authorities, physicians/specialists or opinion leaders, and internal R&D departments.


  • Define the strategy for clinical research in close collaboration with the medical management and in accordance with the company's strategic priorities.
  • Take charge of the strategy, approach and development of clinical activities for the approval of a novel drug.
  • Establish the strategy and direct the clinical plan for each product.
  • Define relationships with CROs, supervise clinical trial protocols, identify principal investigators and participate in working groups.
  • Determine the operational and material requirements of studies.
  • Determine the budgets and financing mechanisms required by studies.
  • Work according to stipulated regulations (EMA, FDA) for each type of product and disease.
  • Work under the standards of Good Clinical Practice (GCP) and the company's corporate responsibility.
  • Ensure that patients participating in the study are informed about new drugs.
  • Write scientific papers on conclusions regarding the efficacy and safety of medicines, and present results in journals and congresses.
  • Define and coordinate the training of team members: assistants, clinical trial monitors (CRA), biostatisticians and computer engineers.
  • Disclose the latest clinical reports to opinion leaders, academics, experts, scientists and physicians.

Quick access and copyright:

Centre per al desenvolupament professional Porta22
Convent de Sant Agustí
Ca n'Andalet

Barcelona Treball (Porta22)
+34 934 019 899

Barcelona Activa Headquarters
Llacuna, 162-164
08018 Barcelona
+34 934 019 777

Generalitat de Catalunya
Unió Europea FEDER
Unió Europea FSE